Search results
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 2 hours agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 5 hours agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 1 day agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 1 day agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Trending tickers: Berkshire Hathaway, Nvidia, Novavax and Adani Enterprises
Yahoo Finance UK· 9 hours agoIts current market cap of $2.695tn puts Nvidia in third position behind Microsoft (MSFT) and Apple...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
InvestorPlace· 8 hours agoUndervalued biotech stocks can offer some of the most explosive opportunities. Many times, biotech...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday -...
Benzinga· 1 day agoNovavax, Inc . NVAX rose 10.7% to $16.65. Twist Bioscience Corporation TWST gained...statements. Denali Therapeutics Inc. DNLI jumped 8.1% to $20.06 as the company said that ...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 6 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...